geert vanden bossche mass vaccination in a pandemic

The technology obviates the need for traditional adjuvants, multiple boost injections or expensive manufacturing processes and is readily compatible with intradermal or mucosal administration. He claims that its because theres so much coronavirus circulating and so many people might produce suboptimal levels of antibody to the virus that, as is the case when antibiotics are used at levels too low to eliminate bacteria and thereby result in strong evolutionary selection for resistant strains of bacteria, a mass vaccination program is doomed to result in resistant variants of coronavirus, particularly when the vaccination program has started out targeted: As if this was not already heavily compromising innate immune defense in this population segment, there comes yet another force into play that will dramatically enhance morbidity and mortality rates in the younger age groups: MASS VACCINATION of the ELDERLY. . Visit Geert at https://www.voiceforscienceandsolidarity.org/ and stay updated on his latest blogs, projects, and videos. untested waters given that widespread use of low-effectiveness vaccines did not exist in humans prior to the COVID-19 pandemic of 2020. 'Mass vaccination campaigns conducted on a background of high infectivity rates will dramatically increase the likelihood of previously asymptomatically . This will, indeed, require large vaccination campaigns. THE LAST POST by Dr Geert Van Den Bossche - LinkedIn The situation is just too urgent! For Dr. Bossche, however, the solution is not long walks on the beach, but an alleged new type of vaccine focused on training the innate immune system. Geert Vanden Bossche on Twitter: "Continued mass vaccination will only Saltar al contenido principal.es. It is, as McGill's Jonathan Jarry wrote and as Yale's Omer told us, a classic example of the appeal-to-nature fallacy that invokes the primacy of natural solutions, mechanisms, or substances over those deemed unnatural and human created. So-called leaky vaccines are vaccines that prevent disease, but do not appreciably slow transmission of the pathogen. The role of spike protein variability inT cell immunity is likely to be elucidated in experimental studies in the next few months; a priori, the enhanced repertoire of T cell epitopes makes the loss of cytotoxic activity or recognition improbable. Countering Geert Vanden Bossche's dubious viral open letter warning Thus if evidence emerges that particular variants do appear to influence vaccine efficacy, it should be possible to periodically reformulate the vaccines so that they better match the circulating strains. To follow Dr . Racing against the clock, I am completing my scientfic [sic] manuscript, the publication of which is, unfortunately, likely to come too late given the ever increasing threat from rapidly spreading, highly infectious variants. Explanation: Experts say there is no evidence of that happening so far. Basically, innate immunity is a bit like Dory the amnesiac fish from Finding Nemo. One of the cell types of the innate immune system is a natural killer cell, and Dr. Bossche claims to be developing a natural killer cell vaccine. Vanden Bosche argues that widespread vaccination will put evolutionary pressure on the viruses to develop adaptations in this case changes to the spike protein that allows the virus to infect cells in a way that will allow it to escape the vaccine's protection.

Abandoned Houses In Bucks County, Pa, Articles G